| The new method of coagulation of blood vessels (TargetCreationTechnology) allows practitioners to solve common problems, such as: - impossibility to coagulate large vessels or vessels lying deep; - overheating of surrounding tissues and resulting risk of scarring; - influence on normal pigmentation of the skin.
These problems cannot be solved by traditional methods because they are stringently restricted in application. Firstly, it is impossible to choose a wavelength at which oxyhemoglobin of blood will absorb the emission and other substances of the skin will not. For instance, melanin (pigment) contained in the skin absorbs the emission far better than oxyhemoglobin of the blood and impedes it from penetrating deeper. Secondly, the volume and, as a consequence, heat capacity of vessels on one area of the skin can vary dozens of times, thus making it impossible to select an optimal pulse length for all of them. For small vessels the influence will be excessive – the vessel will overheat and pass the heat to the surrounding tissues which willin tu , result in their overheating and scarring. For big vessels, on the contrary, the heat will be insufficient and they will not be coagulated. How, therefore, is it possible to ensure an appropriate level of selectivity of laser exposure to avoid undesirable consequences? The new method of coagulation of blood vessels (TargetCreationTechnology) simultaneously uses two wavelengths of laser emission. The first wavelength is absorbed not only by hemoglobin, but also by melanin. Its power is sufficient to create tiny areas of coagulated blood, but insufficient to change the natural pigmentation of the skin. The importance of the high-powered pulse of the second wavelength is decisive, concentrating on the substance of coagulated blood rather than absorption centres in the biological tissues. Therefore, the first wavelength creates the target for the second wavelength – a small area of coagulated blood on the surface of the vessel. The second wavelength has no efficient absorption centres in the biological tissues except coagulated blood - the target created by the first wavelength. The application of the new technology ensures instant heating and coagulation of the whole blood vessel (with diametre up to several millimetres, including vessels on the legs). After the treatment the blood vessel darkens indicating its coagulation. Painful sensations are negligible; there is no need for anaesthesia or cooling of the skin. The peculiar feature of this method is its high selectivity – not all of the area of exposure is heated, but rather only the blood vessels. Therefore, the overheating of surrounding tissues and risk of scarring are excluded. Fig. 1. Exposure of blood vessels to the laser emission. Fig. 2. Coagulation of large and small vessels without swelling. Fig. 3. Disappearance of coagulated blood vessels.
Application: hemangiomas (capillary, cave ous), telangiectasia (arterial, venous, mixed). Complete treatment: 1-3 procedures. Laser type: Nd:YAP/KTP/Q-switched. The method is patented and can be applied only by LINLINE GmbH.
|